OfficeHours

OCTOBER 20, 2023

High inflation might make IPOs more attractive as public markets can provide better protection against inflation whereas selling to strategic buyers or secondary buyers (i.e. Networking strategies Skill development Job searching tips Resume and interview guidance So you want to pursue a role at a Hedge Fund?

Investors 130

Investors Private Equity Equities Debt 130

Mergers and Inquisitions

SEPTEMBER 20, 2023

Q: Why not private equity, growth equity, hedge funds, or entrepreneurship? A: You’re most interested in tech or life science startups, and PE funds and hedge funds do not work with these companies in the same way, as they don’t directly fund their development activities. Q: Which current startup would you invest in?

Capital 59

Capital Valuation Investment Portfolio 59

Devensoft

AUGUST 21, 2023

From sourcing deals and conducting due diligence to negotiating terms and post-acquisition management, these power players navigate complex landscapes with enormous financial stakes. By providing funding and expertise, VCs help startups scale rapidly and attract the attention of potential acquirers.

Private Equity 52

Private Equity M&A Equities Mergers and Acquisitions 52

Cooley M&A

JANUARY 25, 2023

2022 drivers and headwinds Choppy access to capital markets and financing to fund ongoing operations Many life sciences companies faced challenges raising money in the capital markets in 2022. Let’s dig in. That said, some buyers took a wait-and-see approach in 2022.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

APRIL 5, 2024

Public companies and companies contemplating an IPO are in a trickier situation. It has been common market practice for founders, private equity sponsors and other controlling stockholders to retain governance rights over a controlled company after an IPO, often through a stockholder agreement with the IPO issuer.

M&A 52

M&A Mergers and Acquisitions Mergers Corporation 52

Cooley M&A

NOVEMBER 1, 2018

government shutdown disrupting the market for IPOs, Brexit uncertainty, natural disasters and various other crises, cross-border M&A activity momentum continues. In what remains largely a low organic growth environment, deals were being funded by the record levels of dry powder held by private equity and cash piles repatriated by U.S.

M&A 52

M&A Mergers and Acquisitions Government Business 52

Cooley M&A

JANUARY 20, 2022

On the other side of the negotiating table, however, we still don’t take as a given that strategic acquirers blanketly utilize insurance products. The volume of SPAC IPOs in 2021 shattered previous records, but most came in the first quarter, with more SPAC IPOs in the first quarter of 2021 (298) than all of 2020 combined (248).

M&A 40

M&A Insurance Mergers and Acquisitions IPO 40

Cooley M&A

JANUARY 25, 2023

Going further, rather than arranging upfront committed debt financing, Thoma Bravo opted to fund the purchase price for its announced $2.3 Looking forward, we should expect even more enforcement as the agencies continue to execute the Biden administration’s mandate for increased enforcement and receive additional funding for that mission.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Cooley M&A

JANUARY 20, 2022

A notable example was a consortium of PE funds agreeing to acquire a majority stake in Medline for $34 billion. These divestiture transactions often result in new, leaner players with extra cash to fund future operational and strategic objectives. term average of approximately 35%. time highs in 2021.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Growth Business

APRIL 10, 2025

By Anna Jordan on Growth Business - Your gateway to entrepreneurial success University spinouts continue to make an impression on the business landscape, securing millions during funding rounds and getting investment from some high-profile venture capitalists. Theyve made an impressive four exits, made up of two acquisitions and two IPOs.

Equities 66

Equities Engineering Investors Funds 66

Cooley M&A

JANUARY 22, 2025

This approach, combining M&A and initial public offering (IPO) preparations on parallel tracks, allows companies to maximize optionality in an uncertain market. Of course, the targets leverage in the M&A track of a dual-track process inherently increases when the IPO track is a viable strategy.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64

Cooley M&A

FEBRUARY 15, 2017

Dealmakers appear much more optimistic in the first quarter of 2017 than at this same time last year, in part because of greater optimism about the IPO market and the potential for favorable corporate tax and other regulatory changes. Negotiating Anti-Reliance Language. Innovation Pressures Fuel M&A. Appraisal Risks Factor High.

M&A 40

M&A IPO Pharmaceutical Valuation 40

Cooley M&A

FEBRUARY 3, 2025

The tech deal floodgates still havent opened, as persistent valuation mismatches, a still (mostly) closed tech IPO market, stiff competition and worldwide regulatory scrutiny continue to weigh on activity, particularly for VC-backed exits and mega deals. billion acquisition of Altair, IBMs pending $6.4 So is tech M&A back?

M&A 59

M&A Mergers and Acquisitions Private Equity Acquisitions 59